Development and Validation of a Risk Calculator for Post-discharge Venous Thromboembolism Following Hepatectomy for Malignancy
Overview
Affiliations
Background: Post-discharge venous thromboembolism (VTE) chemoprophylaxis decreases VTEs following cancer surgery, however identifying high-risk patients remains difficult. Our objectives were to (1) identify factors available at hospital discharge associated with post-discharge VTE following hepatectomy for malignancy and (2) develop and validate a post-discharge VTE risk calculator to evaluate patient-specific risk.
Methods: Patients who underwent hepatectomy for malignancy from 2014 to 2017 were identified from the ACS NSQIP hepatectomy procedure targeted module. Multivariable logistic regression identified factors associated with post-discharge VTE. A post-discharge VTE risk calculator was constructed, and predicted probabilities of post-discharge VTE were calculated.
Results: Among 11 172 patients, 95 (0.9%) developed post-discharge VTE. Post-discharge VTE was associated with obese BMI (OR 2.29 vs. normal BMI [95%CI 1.31-3.99]), right hepatectomy/trisegmentectomy (OR 1.63 vs. partial/wedge [95%CI 1.04-2.57]), and several inpatient postoperative complications: renal insufficiency (OR 5.29 [95%CI 1.99-14.07]), transfusion (OR 1.77 [95%CI 1.12-2.80]), non-operative procedural intervention (OR 2.97 [95%CI 1.81-4.86]), and post-hepatectomy liver failure (OR 2.22 [95%CI 1.21-4.08]). Post-discharge VTE risk ranged from 0.3% to 30.2%. Twenty iterations of 10-fold cross validation identified internal validity.
Conclusions: Risk factors from all phases of care, including inpatient complications, are associated with post-discharge VTE following hepatectomy. Identifying high-risk patients may allow for personalized risk-based post-discharge chemoprophylaxis prescribing.
Surgical Implications for Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.
Anbarasu C, Williams-Perez S, Camp E, Erstad D Cancers (Basel). 2024; 16(16).
PMID: 39199546 PMC: 11352989. DOI: 10.3390/cancers16162773.
Venous Thromboembolism Chemoprophylaxis Adherence Rates After Major Cancer Surgery.
Logan C, Hudnall M, Schlick C, French D, Bartle B, Vitello D JAMA Netw Open. 2023; 6(9):e2335311.
PMID: 37768664 PMC: 10539988. DOI: 10.1001/jamanetworkopen.2023.35311.
Karunakaran M, Kaur R, Ismail S, Cherukuru S, Jonnada P, Senadhipan B Langenbecks Arch Surg. 2022; 407(8):3221-3233.
PMID: 35881311 PMC: 9722838. DOI: 10.1007/s00423-022-02610-9.